Patient-reported outcome measurement in drug discovery: a tool to improve accuracy and completeness of efficacy and safety data

Focusing on Core Patient-Reported Outcomes in Cancer Clinical Trials: Symptomatic Adverse Events, Physical Function, and Disease-Related Symptoms

(2016) P. G. Kluetz et al.   CLINICAL CANCER RESEARCH

Effects of Cabozantinib on Pain and Narcotic Use in Patients with Castration-resistant Prostate Cancer: Results from a Phase 2 Nonrandomized Expansion Cohort

(2015) Ethan Basch et al.   EUROPEAN UROLOGY

Equivalence of electronic and paper administration of patient-reported outcome measures: a systematic review and meta-analysis of studies conducted between 2007 and 2013

(2015) Willie Muehlhausen et al.   Health and Quality of Life Outcomes

Patient-Reported Outcomes in Cancer Drug Development and US Regulatory Review

(2015) Ethan Basch et al.   JAMA Oncology

Pleiotropic Associations of Risk Variants Identified for Other Cancers With Lung Cancer Risk: The PAGE and TRICL Consortia

(2014) S. Lani Park et al.   JNCI-Journal of the National Cancer Institute

The symptom burden of cancer: Evidence for a core set of cancer-related and treatment-related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study

(2013) Charles S. Cleeland et al.   CANCER

Integration of patient-reported outcomes in multiregional confirmatory clinical trials

(2013) Ari Gnanasakthy et al.   Contemporary Clinical Trials

Harnessing Technology to Improve Clinical Trials: Study of Real-Time Informatics to Collect Data, Toxicities, Image Response Assessments, and Patient-Reported Outcomes in a Phase II Clinical Trial

(2013) M. Catherine Pietanza et al.   JOURNAL OF CLINICAL ONCOLOGY

Cumulative response curves to enhance interpretation of treatment differences on the Self-Esteem And Relationship questionnaire for men with erectile dysfunction

(2012) Joseph C. Cappelleri et al.   BJU INTERNATIONAL

Prospective, Observational Study of Pain and Analgesic Prescribing in Medical Oncology Outpatients With Breast, Colorectal, Lung, or Prostate Cancer

(2012) Michael J. Fisch et al.   JOURNAL OF CLINICAL ONCOLOGY

A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis

(2012) Srdan Verstovsek et al.   NEW ENGLAND JOURNAL OF MEDICINE

Reasons for Rejection of Patient-Reported Outcome Label Claims: A Compilation Based on a Review of Patient-Reported Outcome Use among New Molecular Entities and Biologic License Applications, 2006–2010

(2012) Carla DeMuro et al.   VALUE IN HEALTH

A Review of Patient-Reported Outcome Labels in the United States: 2006 to 2010

(2012) Ari Gnanasakthy et al.   VALUE IN HEALTH

Reliability of adverse symptom event reporting by clinicians

(2011) Thomas M. Atkinson et al.   QUALITY OF LIFE RESEARCH

Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 2—Assessing Respondent Understanding

(2011) Donald L. Patrick et al.   VALUE IN HEALTH

Health care providers underestimate symptom intensities of cancer patients: A multicenter European study

(2010) Eivor A. Laugsand et al.   Health and Quality of Life Outcomes

Equivalence of Electronic and Paper-and-Pencil Administration of Patient-Reported Outcome Measures: A Meta-Analytic Review

(2007) Chad J. Gwaltney et al.   VALUE IN HEALTH